Table 4 Outcomes for patients in two groups
| Â | Not propensity score matched | Propensity score matched | |||||
|---|---|---|---|---|---|---|---|
Entire cohort (n = 91) | Prone group (n = 38) | Supine group (n = 53) | p | Prone group (n = 25) | Supine group (n = 25) | p | |
Organ failure [n(%)] | |||||||
 Renal | 47 (54) | 22 (57.9) | 25 (51) | 0.523 | 15 (60) | 15 (56) | 0.774 |
 Cardiovascular | 52 (58.4) | 19 (51.4) | 33 (63.5) | 0.253 | 13 (52) | 18 (72) | 0.145 |
 Hepatic | 26 (29.6) | 10 (27) | 16 (31.4) | 0.659 | 8 (32) | 8 (32) | 1 |
 Coagulation | 17 (18.9) | 7 (18.9) | 10 (19.6) | 0.936 | 6 (24) | 3 (12) | 0.269 |
 Central nervous system | 21 (24.1) | 8 (21.6) | 13 (26.0) | 0.637 | 6 (24) | 9 (37.5) | 0.305 |
 ≥ 1 organ failure | 67 (73.6) | 27 (71.1) | 40 (75.5) | 0.637 | 19 (76) | 20 (80) | 0.733 |
 ≥ 2 organs failure | 43 (47.3) | 18 (47.4) | 25 (47.2) | 0.985 | 14 (56) | 14 (56) | 1 |
ICU survival [n (%)] | 33 (36.3) | 16 (42.1) | 17 (32.1) | 0.326 | 10 (40) | 8 (32) | 0.556 |
Hospital survival [n (%)] | 29 (31.9) | 16 (42.1) | 13 (24.5) | 0.076 | 10 (40) | 7 (28) | 0.370 |
ECMO weaning [n (%)] | 38 (41.8) | 20 (52.6) | 18 (47.4) | 0.075 | 14 (56) | 8 (32) | 0.087 |
Treatment abandoning [n (%)] | 24 (26.4) | 7 (18.4) | 17 (32.1) | 0.145 | 3 (12.5) | 7 (28) | 0.289 |
Length of ICU stay (d) | 19 (9.8–35) | 28.7 (17–47) | 14 (5.7–23.5) | < 0.001b | 28.33 (16–40.5) | 14 (6.69–25.94) | 0.014a |
Length of hospital stay (d) | 23 (11–38) | 31.5 (17.5–59.75) | 15 (6.5–26.5) | < 0.001b | 30 (17–40.5) | 16 (8–27) | 0.018a |
Duration of ECMO support (d) | 10 (5–17) | 14 (8.5–29.25) | 8 (3–13) | 0.001b | 14.5 (9.25–29.75) | 8 (3.25–16) | 0.007b |
MV duration (d) | 13 (7–26.25) | 19 (11.5–43.25) | 11 (4.25–17.75) | 0.002b | 14 (12–43) | 13 (7–20) | 0.169 |